Find the latest pharmaceutical market place for formulations enquiry about Budesonide on PharmaCompass.com.

Budesonide + Formoterol Inhalation Powder needed in Indonesia [ENA15315]

A company based in Indonesia that deals in the import, export and distribution of various pharmaceutical products is looking for suppliers of Budesonide (160 mcg) + Formoterol (4.5 mcg) Inhalation Powder for commercial purpose. The required quantity is 9,200 units for first year, 12,200 units for second year and 18, 325 units for third year.

Reply

14 Oct 2022

Tender// Budesonide Inhalation Suspensions needed in Bulgaria [ENA13857]

Mnogoprofilna Bolnitsa Za Aktivno Lechenie - Asenovgrad Eood is looking for supplies of Budesonide (0.25 mg/ ml in 2 ml) Inhalation Suspensions for commercial purpose. The required quantity is 4,000 units. The deadline is 1-Jul-2022.

Reply

03 Jun 2022

Tender// Various Finished Dosage Formulations needed in Poland [ENA13579]

Poviat Hospital in Chrzanow is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 9-Jun-2022.
1. Doxazosin (4 mg) Tablets. The required quantity is 5,400 units.
2. Norepinephrine (1 mg/ ml in 4 ml) Solution for Infusions. The required quantity is 6,000 units.
3. L-Ornithine L-aspartate (150 mg) Tablets. The required quantity is 9,200 units.
4. Budesonide (0.25 mg/ 2 ml) Ampoules. The required quantity is 6,000 units.

Reply

09 May 2022

Tender// Various Finished Dosage Formulations needed in Poland [ENA13452]

Poviat Hospital in Chrzanow is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 30-May-2022.
1. Ciprofloxacin (2 mg/ ml in 200 ml) Solution for Infusions. The required quantity is 8,000 units.
2. Ceftriaxone (2 g) Powder for Solution for Injections or Infusions. The required quantity is 9,000 units.
3. Budesonide (0.25 mg/ ml in 2 ml) Ampoules. The required quantity is 6,000 units.

Reply

27 Apr 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA11521]

Multiprofile Hospital for Active Treatment - Svilengrad Eood is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 1-Nov-2021.
1. Drotaverine (40 mg) Tablets. The required quantity is 10,000 units.
2. Magnesium Aspartate (500 mg) Tablets. The required quantity is 10,000 units.
3. Acetylsalicylic Acid (100 mg) Tablets. The required quantity is 3,000 units.
4. Dydrogesterone (10 mg) Tablets. The required quantity is 2,000 units.
5. Oxytocin (5 IU/ ml in 1 ml) Ampoules. The required quantity is 1,000 units.
6. Nimesulide (100 mg) Tablets. The required quantity is 1,150 units.
7. Paracetamol (500 mg) Tablets. The required quantity is 1,000 units.
8. Midazolam (1 mg/ ml in 5 ml) Ampoules. The required quantity is 2,000 units.
9. Citicoline (1000 mg/ 4 ml) Solution for Injection. The required quantity is 2,000 units.
10. Budesonide (0.25 mg/ ml in 2 ml) Suspensions. The required quantity is 1,200 units.

Reply

29 Sep 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA11469]

Independent Public Health Care is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 20-Oct-2021.
1. Dexmedetomidine (100 µcg/ ml in 2 ml) Ampoules. The required quantity is 1,500 units.
2. Captopril (12.5 mg) Tablets. The required quantity is 5,000 units.
3. Amlodipine (5 mg & 10 mg) Tablets. The required quantity is 4,000 units & 2,400 units respectively.
4. Omeprazole (20 mg) Capsules. The required quantity is 10,000 units.
5. Budesonide (0.5 mg/ ml in 2 ml) Solution for Inhalation. The required quantity is 3,300 units.
6. Furosemide (20 mg/ 2 ml) Ampoules. The required quantity is 7,200 units.
7. Furosemide (40 mg) Tablets. The required quantity is 3,000 units.
8. Ketoprofen (100 mg) Tablets. The required quantity is 18,000 units.
9. Omeprazole (20 mg) Capsules. The required quantity is 9,000 units.
10. Carvedilol (6.25 mg) Tablets. The required quantity is 1,500 units.

Reply

22 Sep 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA11359]

Provincial Specialist Hospital for them st. Rafal in Czerwona Gora is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 11-Oct-2021.
1. Ciprofloxacin (0.5 g) Tablets. The required quantity is 5,370 units.
2. Cefuroxime (1.5 g) Injections. The required quantity is 6,010 units.
3. Ceftriaxone (1 g) Injections. The required quantity is 6,240 units.
4. Cefotaxime (1 g) Injections. The required quantity is 35,120 units.
5. Ceftazidime (1 g) Intravenous and Intramuscular Injection and Infusion. The required quantity is 5,930 units.
6. Budesonide (0.4 g) Capsules for Inhalation. The required quantity is 3,120 units.
7. Amiodarone (0.15 g/ 3 ml) Ampoules. The required quantity is 2,970 units.
8. Acetylsalicylic Acid (0.075 g) Tablets. The required quantity is 12,960 units.
9. Lidocaine (2% of 0.2 g/ 10 ml) Ampoules. The required quantity is 10,220 units.
10. Bupivacaine (0.5% of 0.02 g/ 4 ml) Ampoules. The required quantity is 1,740 units.
11. Rifampicin (0.3 g) + Isoniazid (0.15 g) Capsules. The required quantity is 13,100 units.
12. Metronidazole (0.25 g) Tablets. The required quantity is 6,280 units.
13. Fentanyl (0.1 mg/ 2 ml) Ampoules. The required quantity is 6,500 units.
14. Amikacin (0.5 g/ 2 ml) Ampoules. The required quantity is 1,757 units.

Reply

10 Sep 2021

SaudiArabia Flag

e-CTD Dossiers for Various Finished Dosage Formulations needed in Saudi Arabia [ENA10978]

Egylava, a company that deals in the distribution & wholesaling of pharmaceutical, medical equipment, & health care products is looking for suppliers of e-CTD Dossiers for the Finished Dosage Formulations or Technology Transfer for commercial purpose. Interested suppliers can contact them via their email: bdm@egylava.com.
1. Ursodeoxycholic Acid (250 mg) Capsules
2. Hydromorphone Hydrochloride (1 mg/ ml) Oral Liquid
3. Budesonide (0.5 mg/ ml) Solution Vials for Nebulizing
4. Chymotrypsin 300 E.A.U. (14 micro Katals) + Trypsin 300 E.A.U. (5 micro Katals) Tablets

Reply

29 Jul 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA10727]

University Hospital in Krakow is looking for supplies of Various Finished Dosage Formulations. The deadline is 7-July-2021.
1. Rosuvastatin (5 mg, 10 mg and 20 mg) Oral Solid Form. The required quantity is 1,080 units, 16,200 units and 13,500 units respectively.
2. Amlodipine (5 mg and 10 mg) Oral Solid Form. The required quantity is 50,400 units and 21,600 units respectively.
3. Ciprofloxacin (500 mg) Oral Solid Form. The required quantity is 7,200 units.
4. Ramipril (2.5 mg, 5 mg and 10 mg) Oral Solid Form. The required quantity is 8,064 units, 35,280 units and 11,200 units respectively.
5. Sertraline (50 mg) Oral Solid Form. The required quantity is 30,240 units.
6. Budesonide (0.5 mg/ 2 ml and 1 mg/ 2 ml) nebuliser suspension. The required quantity is 21,000 units and 11,000 units respectively.
7. Bisoprolol (5 mg) Powder. The required quantity is 43,500 units.
8. Digoxin (250 mcg) Oral Solid Form. The required quantity is 3,000 units.
9. Sertraline (50 mg) Oral Solid Form. The required quantity is 30,240 units.
10. Tranexamic Acid (100 mg/ ml in 5 ml) Solution for Intravenous Injection, Amp. The required quantity is 28,800 units.

Reply

28 Jun 2021

Various Finished Dosage Formulations needed in Brazil [ENA10426]

A company with more than 40 years of experience in the pharmaceutical industry that aims to provide a reliable and efficient source of supply is looking for suppliers of Various Finished Dosage Formulations for development purposes. The suppliers must support this enquiry with CoA.
1. Budesonide + Formoterol (12/ 400 mcg, 6/ 100 mcg, 6/ 200 mcg, 6/ 400 mcg) Inhalation Powder Device
2. Budesonide (0.25 mg x 2ml x 20 & 0.5 mg x 2ml x 20) Suspension
3. Benserazide + Levodopa (200 mg + 50 mg, 100 mg + 25 mg, Dispersible 125 mg + 250 mg) Tablets

Reply

15 May 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA10324]

Institute "Children's Memorial Health Center" is looking for supplies of Various Finished Dosage Formulations. The deadline is 12-May-2021.
1. Drotaverine (20 mg/ ml) Ampoule. The required quantity is 416 units.
2. Budesonide (0.25 mg/ ml) Suspension for Inhalation from a Nebuliser. The required quantity is 215 units.
3. Levetiracetam (100 mg/ ml) Concentrate for Solution for Infusion. The required quantity is 71 units.
4. Benzylpenicillin (1 MU) Vials. The required quantity is 280 units.
5. Linezolid (2 mg/ ml) Solution for Infusion. The required quantity is 250 units.
6. Rocuronium Bromide (10 mg/ ml) Vials. The required quantity is 234 units.

Reply

03 May 2021

Tender// Various Finished Formulations needed in Estonia [ENA09101]

Procurement of medicinal products as provided for in the basic public procurement documents. The North Estonian Regional Hospital of The North Estonian Regional Hospital of The University of Estonia represents the Maa County Hospital and Raplamaa Hospital of the Sa, by proxy. The deadline is 01-Dec-2020.
1. Budesonide (0.25 mg/ ml in 2 ml) Nebulizable Suspension
2. Acetylcysteine (100 mg/ ml in 3ml) Solution for Injection
3. Acetylcysteine (200 mg & 600 mg) Effervescent Tablet or Powder for Oral Solution
4. Ferrous (II) Sulfate (100mg) Prolonged-Release Tablet
5. Clotrimazole (10 mg/ g in 20 g) Cream
6. Clobetasol (500 mcg/ g in 25 g) Cream

Reply

21 Nov 2020

SaudiArabia Flag

Budesonide (0.25 mg/ ml & 0.5 mg/ ml) Suspension needed in Saudi Arabia [ENA08669]

A pharmaceutical company that deals in the wholesale distribution of pharmaceutical, herbal and cosmetic products is looking for suppliers of Budesonide (0.25 mg/ ml & 0.5 mg/ ml) Suspension. The required quantity is 50,000 units for each per annum. The suppliers must support this enquiry with eCTD.

Reply

28 Sep 2020

Looking for EUCTD Dossiers of Various Finished Dosage Formulations [ENA06901]

A large company based in Poland, that specializes in the production of prescription generic drugs in the field of pulmonology, cardiology, gastrology, neurology, dermatology, and gynecology is looking for EUCTD Dossiers of Various Finished Dosage Formulations:
1. Allopurinol 100 mg & 300 mg Tablet
2. Budesonide 0.25 mg/ 2 ml, 0.5 mg/ 2 ml & 1 mg/ 2 ml Ampules for Nebulization
3. Eplerenone 25 mg Film Coated Tablet
4. Fenofibrate 160 mg & 215 mg Tablets Supra, 160 mg & 215 mg Film Coated Tablets & 267 mg Capsule
5. Lacidipine 2 mg & 4 mg Coated Tablet
6. Lercanidipine 10 mg & 20 mg Film Coated Tablet
7. Torasemide 2.5 mg, 5 mg & 10 mg Tablet
8. Zofenopril 30 mg Film Coated Tablet

Reply

21 Mar 2020

Various finished formulations needed in Ukraine [ENA05318]

A leading medical technology company that manufacture, market and distributes a variety of products and services is looking for suppliers of below mentioned finished formulations . The supplier must support this enquiry with EUGMP or Ukraine GMP. The required packaging will be 10 Nebules.
1. Budesonide (0.5 mg/2 ml) Respules: 1st order quantity- 30,000 units, 2nd order quantity 50,000 units
2. Budesonide (1 mg/2 ml) Respules: 1st order quantity- 30,000 units, 2nd order quantity 50,000 units
3. Salbutamol (2.5 mg/2.5 ml) Respules: 1st order quantity- 30,000 units, 2nd order quantity 50,000 units
4. Fluticasone Propionate (0.5 mg/2 ml) Respules: 1st order quantity- 15,000 units, 2nd order quantity 20,000 units.

Reply

01 Oct 2019

Everolimus tablets and Budesonide nasal spray formulations needed in China [ENA04709]

A full-service, strategic advisory firm is looking for suppliers of Everolimus tablet and Budenoside nasal spray formulations for China market. The required dosage strength and quantity is mentioned below for the products:
1. Everolimus tablets (2.5mg/5mg/10mg) - 120,000 units
2. Budenoside nasal spray (100 mg) Vials - 2,000,000 units

Reply

24 Jul 2019

Enquiry// Budesonide respules needed in Lebanon [ENA00208]

Katena Lab, a Lebanese wholesaler and distributor of pharmaceuticals, paramedical and medical equipment is looking for suppliers of Budesonide repsules with all necessary regulatory documents needed for registration and supply into Lebanon. Interested suppliers may contact them at hamdan.lakis@katenalab.com.

Reply

14 Feb 2017